BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34091544)

  • 21. Pyloric sphincter characteristics using EndoFLIP
    Saadi M; Yu D; Malik Z; Parkman HP; Schey R
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):375-384. PubMed ID: 29709494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative Endoscopic Botox Injection During Total Esophagectomy Prevents the Need for Pyloromyotomy or Dilatation.
    Fuchs HF; Broderick RC; Harnsberger CR; Divo FA; Coker AM; Jacobsen GR; Sandler BJ; Bouvet M; Horgan S
    J Laparoendosc Adv Surg Tech A; 2016 Jun; 26(6):433-8. PubMed ID: 27043862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum Toxin Injection for Treatment of Gastroparesis.
    Pasricha TS; Pasricha PJ
    Gastrointest Endosc Clin N Am; 2019 Jan; 29(1):97-106. PubMed ID: 30396531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type A for treatment of refractory gastroparesis.
    DeSantis ER; Huang S
    Am J Health Syst Pharm; 2007 Nov; 64(21):2237-40. PubMed ID: 17959574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of endoscopic pyloric balloon dilation in patients with refractory gastroparesis.
    Soliman H; Oiknine E; Cohen-Sors B; Moszkowicz D; Gorbatchef C; Dior M; Nebunu N; Le Gall M; Coffin B; Duboc H
    Surg Endosc; 2022 Nov; 36(11):8012-8020. PubMed ID: 35437639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum Toxin A Improves Symptoms of Gastroparesis.
    Reichenbach ZW; Stanek S; Patel S; Ward SJ; Malik Z; Parkman HP; Schey R
    Dig Dis Sci; 2020 May; 65(5):1396-1404. PubMed ID: 31617132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease.
    Triadafilopoulos G; Gandhy R; Barlow C
    Parkinsonism Relat Disord; 2017 Nov; 44():33-37. PubMed ID: 28847681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.
    Arts J; Holvoet L; Caenepeel P; Bisschops R; Sifrim D; Verbeke K; Janssens J; Tack J
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1251-8. PubMed ID: 17944739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrapyloric Botulinum Toxin Injection for Refractory Nausea and Vomiting in Pediatric Patients.
    Osgood PT; Essner BS; Fountain L; Sullivan EC; Meegan C; Fortunato JE
    J Pediatr Gastroenterol Nutr; 2023 Dec; 77(6):726-733. PubMed ID: 37794574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis.
    Wellington J; Scott B; Kundu S; Stuart P; Koch KL
    Auton Neurosci; 2017 Jan; 202():56-61. PubMed ID: 27460691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic treatment of gastroparesis.
    McCarty TR; Rustagi T
    World J Gastroenterol; 2015 Jun; 21(22):6842-9. PubMed ID: 26078560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum Toxin as a Treatment for Feeding Difficulties in Young Children.
    Hirsch S; Nurko S; Mitchell P; Rosen R
    J Pediatr; 2020 Nov; 226():228-235. PubMed ID: 32599032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative endoscopic pyloric balloon dilatation decreases the rate of delayed gastric emptying after Ivor-Lewis esophagectomy.
    Hadzijusufovic E; Tagkalos E; Neumann H; Babic B; Heinrich S; Lang H; Grimminger PP
    Dis Esophagus; 2019 Jun; 32(6):. PubMed ID: 30508077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapyloric injection of botulinum toxin a for the treatment of persistent gastroparesis following successful pancreas transplantation.
    Ben-Youssef R; Baron PW; Franco E; Walter MH; Lewis T; Ojogho O
    Am J Transplant; 2006 Jan; 6(1):214-8. PubMed ID: 16433778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting.
    Hirsch S; Nurko S; Liu E; Rosen R
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14428. PubMed ID: 35811408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of gastroparesis with botulinum toxin in patient after allogenic bone marrow  transplantation.
    Galstyan GM; Pashkova MV; Popova OY; Makarova PM; Dubnyak DS; Kuzmina LA; Parovichnikova EN
    Ter Arkh; 2018 Feb; 90(1):60-64. PubMed ID: 30701760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyloric distensibility in health and disease.
    Wuestenberghs F; Gourcerol G
    Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G133-G138. PubMed ID: 34160292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic
    Nevins EJ; Rao R; Nicholson J; Murphy KD; Moore A; Smart HL; Stephens N; Grocock C; Kaul A; Gunasekera RT; Hartley MN; Howes NR
    Ann R Coll Surg Engl; 2020 Nov; 102(9):693-696. PubMed ID: 32538118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrapyloric botulinum injection increases postoperative esophagectomy complications.
    Eldaif SM; Lee R; Adams KN; Kilgo PD; Gruszynski MA; Force SD; Pickens A; Fernandez FG; Luu TD; Miller DL
    Ann Thorac Surg; 2014 Jun; 97(6):1959-64; discussion 1964-5. PubMed ID: 24793689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Techniques and devices for the endoscopic treatment of gastroparesis (with video).
    Parsi MA; Jirapinyo P; Abu Dayyeh BK; Bhutani MS; Chandrasekhara V; Krishnan K; Kumta NA; Melson J; Pannala R; Trikudanathan G; Trindade AJ; Sethi A; Watson RR; Maple JT; Lichtenstein DR;
    Gastrointest Endosc; 2020 Sep; 92(3):483-491. PubMed ID: 32684298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.